Cordatus Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Cordatus Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,072	Closed	-$232K	–	203
2021 Q4	$232K	Hold	2,072	–	–	0.07%	152
2021 Q3	$260K	Buy	+2,072	New	+$267K	0.2%	65
2021 Q1	$281K	Hold	2,072	–	–	0.11%	143
2020 Q4	$292K	Hold	2,072	–	–	0.12%	132
2020 Q3	$231K	Hold	2,072	–	–	0.11%	132
2020 Q2	$232K	Buy	+2,072	New	+$204K	0.13%	109

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Cordatus Wealth Management's XBI Position: Q1 2022 in Review

Cordatus Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2022, closing a stake of 2,072 shares — an estimated $232K sold.

Cordatus Wealth Management first reported a position in XBI in Q2 2020 and held it in 6 quarters. The position peaked at $292K in Q4 2020. 703 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

Cordatus Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2022 after selling out during the quarter.
Cordatus Wealth Management sold 2,072 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $232K.
Cordatus Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 6 quarters.
Cordatus Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $292K in Q4 2020.
703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on Cordatus Wealth Management's 13F filing for Q1 2022, filed 6 May 2022.